| 25 Mar, 04:18 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 21 Mar, 08:16 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India". | nse |
| 21 Mar, 08:12 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 19 Mar, 09:30 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 19 Mar, 09:27 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 19, 2026, titled "Zydus launches Aerolife Mini , to simplify inhaler use for asthma and COPD patients". | nse |
| 18 Mar, 03:11 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Mar, 03:08 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 18, 2026, titled "Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India". | nse |
| 17 Mar, 12:00 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Mar, 12:00 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 17, 2026, titled "Zydus and Lupin sign licensing agreement for co-marketing innovative Semaglutide Injection in India". | nse |
| 16 Mar, 08:15 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 16 Mar, 08:15 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Sentynl Therapeutics Enters into Agreement with PRG S&T to License Molecule for Hutchinson-Gilford Progeria Syndrome". | nse |
| 14 Mar, 01:42 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Mar, 01:39 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 14, 2026, titled "Zydus new drug discovery, Desidustat licensed to China Medical System Holdings receives approval from NMPA of China". | nse |
| 13 Mar, 10:05 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Mar, 10:02 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg". | nse |
| 12 Mar, 02:24 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Mar, 02:21 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Zydus expands companion diagnostics portfolio with the launch of AI-powered Continuous Glucose Monitor DiasensTM and GlucoLiveTM". | nse |
| 28 Feb, 11:16 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Feb, 11:13 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 28, 2026, titled "Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg". | nse |
| 27 Feb, 02:54 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Feb, 02:50 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Zydus Lifesciences announces successful clinical development of Pembrolizumab biosimilar FYB206, marking a milestone toward USFDA filing". | nse |
| 25 Feb, 06:51 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 25 Feb, 06:48 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 25, 2026, titled "Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry, expanding patient access to GLP-1 therapy". | nse |
| 19 Feb, 08:41 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 19, 2026, titled "Closure of USFDAinspection at Zydus Injectable plant at Ahmedabad". | nse |
| 19 Feb, 08:39 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 19 Feb, 09:50 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 19, 2026, titled "Zydus launches biosimilar Aflibercept 2 mg ANYRA for advancing ophthalmic care ". | nse |
| 19 Feb, 09:47 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Feb, 06:10 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Feb, 06:07 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 18, 2026, titled "Zydus receives final approval from USFDA for Bosentan tablets for oral suspension, 32 mg". | nse |
| 17 Feb, 10:21 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Feb, 10:18 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 17, 2026, titled "Zydus launches PEPAIR, a first in India, affordable, drug-free, handheld device for better respiratory health". | nse |
| 15 Feb, 07:20 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Transcript | nse |
| 15 Feb, 07:17 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 14 Feb, 11:14 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Feb, 10:09 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 14, 2026, titled "Zydus receives final approval from USFDA for Ammonium Lactate Cream, 12%". | nse |
| 12 Feb, 08:26 am | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 12 Feb, 08:26 am | — | … | Zydus Lifesciences Ltd - 532321 - Update On Litigation | bse |
| 10 Feb, 05:52 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 10 Feb, 05:48 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Link of Recording | nse |
| 09 Feb, 01:31 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release". | nse |
| 09 Feb, 01:30 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Feb, 01:27 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 09 Feb, 01:26 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 09 Feb, 01:23 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding 'Board comments on penalties levied by BSE and NSE'. | nse |
| 09 Feb, 01:22 pm | — | … | Zydus Lifesciences Ltd - 532321 - Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2025 | bse |
| 09 Feb, 01:20 pm | — | … | Zydus Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 09 Feb, 01:19 pm | — | … | Zydus Lifesciences Ltd - 532321 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2025 | bse |
| 06 Feb, 12:21 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Feb, 12:18 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of Sickle Cell Disease". | nse |
| 04 Feb, 02:40 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |